Investigational Drug Information for AZD4831
✉ Email this page to a colleague
What is the development status for investigational drug AZD4831?
AZD4831 is an investigational drug.
There have been 14 clinical trials for AZD4831.
The most recent clinical trial was a Phase 1 trial, which was initiated on June 30th 2021.
The most common disease conditions in clinical trials are Heart Failure, Cardiovascular Diseases, and Non-alcoholic Fatty Liver Disease. The leading clinical trial sponsors are AstraZeneca, Parexel, and Mayo Clinic.
Summary for AZD4831
US Patents | 0 |
International Patents | 44 |
US Patent Applications | 10 |
WIPO Patent Applications | 1 |
Japanese Patent Applications | 1 |
Clinical Trial Progress | Phase 1 (2021-06-30) |
Vendors | 8 |
Recent Clinical Trials for AZD4831
Title | Sponsor | Phase |
---|---|---|
Pharmacokinetics of Mitiperstat in Participants With Hepatic Impairment | AstraZeneca | Phase 1 |
An Efficacy and Safety Study of AZD4831 (MPO Inhibitor) vs Placebo in the Treatment of Moderate to Severe COPD. | AstraZeneca | Phase 2 |
A Study in Participants With Non-cirrhotic NASH With Fibrosis | AstraZeneca | Phase 2 |
Clinical Trial Summary for AZD4831
Top disease conditions for AZD4831
Top clinical trial sponsors for AZD4831
US Patents for AZD4831
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for AZD4831
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
AZD4831 | Argentina | AR102863 | 2034-12-01 | ⤷ Try a Trial |
AZD4831 | Australia | AU2015357290 | 2034-12-01 | ⤷ Try a Trial |
AZD4831 | Brazil | BR112017011124 | 2034-12-01 | ⤷ Try a Trial |
AZD4831 | Canada | CA2968449 | 2034-12-01 | ⤷ Try a Trial |
AZD4831 | Chile | CL2017001380 | 2034-12-01 | ⤷ Try a Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |